| Revised response criteria for malignant lymphoma BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ... Journal of clinical oncology 25 (5), 579-586, 2007 | 5314 | 2007 |
| Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ... Journal of clinical oncology 25 (5), 571-578, 2007 | 1676 | 2007 |
| Positron-emission tomography and assessment of cancer therapy ME Juweid, BD Cheson New England Journal of Medicine 354 (5), 496-507, 2006 | 930 | 2006 |
| Epidemiology and outcome of glioblastoma AF Tamimi, M Juweid Exon Publications, 143-153, 2017 | 645 | 2017 |
| Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats MJ Abrams, M Juweid, DA Schwartz, MM Hauser, FE Gaul, AJ Fuccello, ... Journal of Nuclear Medicine 31 (12), 2022-2028, 1990 | 571 | 1990 |
| Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier M Juweid, R Neumann, C Paik, MJ Perez-Bacete, J Sato, W van Osdol, ... Cancer research 52 (19), 5144-5153, 1992 | 514 | 1992 |
| Response assessment of aggressive non-Hodgkin’s lymphoma by integrated International Workshop Criteria and fluorine-18–fluorodeoxyglucose positron emission tomography ME Juweid, GA Wiseman, JM Vose, JM Ritchie, Y Menda, JE Wooldridge, ... Journal of Clinical Oncology 23 (21), 4652-4661, 2005 | 493 | 2005 |
| The role of FDG-PET scans in patients with lymphoma P Seam, ME Juweid, BD Cheson Blood, The Journal of the American Society of Hematology 110 (10), 3507-3516, 2007 | 394 | 2007 |
| AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development SN Khleif, JH Doroshow, WN Hait Clinical Cancer Research 16 (13), 3299-3318, 2010 | 232 | 2010 |
| Molecular imaging of proliferation in malignant lymphoma AK Buck, M Bommer, S Stilgenbauer, M Juweid, G Glatting, ... Cancer research 66 (22), 11055-11061, 2006 | 215 | 2006 |
| Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives TM Behr, RM Sharkey, ME Juweid, RD Blumenthal, RM Dunn, GL Griffiths, ... Cancer research 55 (17), 3825-3834, 1995 | 210 | 1995 |
| Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG TM Behr, RM Sharkey, ME Juweid, RM Dunn, RC Vagg, Z Ying, ... Journal of Nuclear Medicine 38 (6), 858-870, 1997 | 177 | 1997 |
| Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody M Juweid, RM Sharkey, A Markowitz, T Behr, LC Swayne, R Dunn, ... Cancer Research 55 (23_Supplement), 5899s-5907s, 1995 | 171 | 1995 |
| Role of positron emission tomography in lymphoma ME Juweid, BD Cheson Journal of Clinical Oncology 23 (21), 4577-4580, 2005 | 167 | 2005 |
| Pharmacokinetics, Dosimetry, and Initial Therapeutic Results with 131I- and 111In-90Y-Labeled Humanized LL2 Anti-CD22 Monoclonal Antibody in Patients with … ME Juweid, E Stadtmauer, G Hajjar, RM Sharkey, S Suleiman, S Luger, ... Clinical cancer research 5 (10), 3292s-3303s, 1999 | 157 | 1999 |
| Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study SJ Horning, ME Juweid, H Schöder, G Wiseman, A McMillan, LJ Swinnen, ... Blood, The Journal of the American Society of Hematology 115 (4), 775-777, 2010 | 156 | 2010 |
| Radioimmunotherapy of B-cell non-Hodgkin’s lymphoma: from clinical trials to clinical practice ME Juweid Journal of Nuclear Medicine 43 (11), 1507-1529, 2002 | 156 | 2002 |
| International Harmonization Project on Lymphoma BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ... Revised response criteria for malignant lymphoma. J Clin Oncol 25 (5), 579-586, 2007 | 154 | 2007 |
| Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies RM Sharkey, M Juweid, J Shevitz, T Behr, R Dunn, LC Swayne, GY Wong, ... Cancer Research 55 (23_Supplement), 5935s-5945s, 1995 | 124 | 1995 |
| Radioimmunotherapy of non-Hodgkin’s lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response? RM Sharkey, A Brenner, J Burton, G Hajjar, SP Toder, A Alavi, A Matthies, ... Journal of Nuclear Medicine 44 (12), 2000-2018, 2003 | 120 | 2003 |
Felix MottaghyDepartment of Nuclear Medicine, University Hospital RWTH Aachen University在 ukaachen.de 的电子邮件经过验证
